Skip to content

Monday, May 29, 2023

Latest:

Is there hidden meaning in “madness”?
Changes in gene p16 create a permissive microenvironment for colon cancer growth
A new education and health sciences building, a new era for Baylor and the TMC
The link between cancer, obesity and metabolic health
Breast cancer tumors remotely disrupt immune response that could stop their own growth

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cancer proteomics

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

From the Labs Image of the Month

From the Labs: The Liver’s biliary tree

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951